Media Pack
News

Current Edition

Volume 7 Issue 2

Upcoming Events

 

Advertisement

 
 
 
 
Building a better healthcare cluster
Volume 3 Issue 1

Building a better healthcare cluster

Science and technology have always been a powerful dynamic in regeneration, and the fourth industrial revolution has many parallels with the first in the way that it ...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Unique Challenges and Opportunities in Orphan Diseases
Volume 3 Issue 1

Unique Challenges and Opportunities in Orphan Diseases

Looking back, the 1983 Orphan Drug Act was a pivotal moment for healthcare, not just in the US but worldwide too. Research on orphan diseases has since flourished, pa...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Geroscience and The Exposome
Volume 3 Issue 1

Geroscience and The Exposome

There has been an unprecedented shift in global demographics, as the human population becomes more aged. This is bringing with it a significant burden of age-related ...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Betting on the Bug, Part III: Leveraging the Microbiome to Generate New Models
Volume 3 Issue 1

Betting on the Bug, Part III: Leveraging the Microbiome to Generate New Models

Interest in the microbiome continues to grow at a robust rate, underlying its potential to significantly benefit human health. In part 1 of this series, the role of t...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Mass Spectrometry Supports Development of New Oligonucleotide Therapeutics
Volume 3 Issue 1

Mass Spectrometry Supports Development of New Oligonucleotide Therapeutics

Oligonucleotides’ ability to inhibit genes or to function as aptamers to interact with protein targets are increasingly vital research tools in the biopharmaceutical ...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Congenital Hyperinsulinism Treatment Gaps and a Potential Solution
Volume 3 Issue 1

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Although rare diseases, by definition, affect fewer individuals than other diseases do, they tend to be particularly devastating: they are often debilitating or letha...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Increasing Patient Access to Advanced Therapies; the UK Perspective
Volume 3 Issue 1

Increasing Patient Access to Advanced Therapies; the UK Perspective

Over the past five years, we have seen remarkable growth and clinical results in an area of medicine known as advanced therapy medicinal products (ATMPs), which compr...
28 July 2020 Volume 3 Issue 1
Continue Reading →
The New Drugs and Clinical Trial Rules of India: A Regulatory Highlights
Volume 3 Issue 1

The New Drugs and Clinical Trial Rules of India: A Regulatory Highlights

The New Drugs and Clinical Trial Rules (NDTC), 2019 were recently issued, emphasising the changes on the regulatory aspects relating to clinical trials. The final doc...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Go-to-market Challenges of CAR-T Therapies
Volume 3 Issue 1

Go-to-market Challenges of CAR-T Therapies

CAR-T therapies are set to revolutionise cancer treatment. With first curative therapies gaining market access across the globe, CAR-T therapies are subject to numero...
28 July 2020 Volume 3 Issue 1
Continue Reading →
Developing Plasmid DNA Production Platforms to Support Novel Gene Therapies
Volume 3 Issue 1

Developing Plasmid DNA Production Platforms to Support Novel Gene Therapies

Epilepsy is a debilitating illness which impacts the life of millions of people across the world. Tony Hitchcock of Cobra Biologics discusses how Cobra Biologics and ...
28 July 2020 Volume 3 Issue 1
Continue Reading →
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte